Background: Amyotrophic lateral sclerosis (ALS) is a serious disease in which some brain and spinal cells die slowly. These nerve cells are called motor neurons and control the muscles that allow the body parts to move. Initially, the disease causes bodily fatigue and muscular weakness through degeneration of the upper and lower motor neurons, leading to loss of ability to initiate and control the voluntary bodily functions. In late stages this disease causes difficulty in the normal swelling and eating that causes the need for PEG in patients with ALS. This clinical picture increases the difficulty and the anesthetic risk used during the PEG application.
Case presentation: We are describing our experience in a 56-year-old male patient, ASA III suffering from ALS and being admitted to our clinic to insert PEG. The patient presented BMI =15.6. After the patient provide informed consent, we were monitoring him for detect changes in pulse oximetry, noninvasive blood pressure, heart rate and visual assessment of ventilator activity, level of consciousness and discomfort. We used balanced propofol for moderate sedation (BPS), loading dose 1mg midazolam, 0.1 mg of fentanyl, and 5-15 mg propofol in smaller bolus dose were applied for more precise dose titration. The operation was performed after the patient lost the consciousness and had no pupil reflex. The EGD entered to the stomach. Fistula was localized after the visualization of light from the tube. Local lidocaine was applied and 1cm incision on the abdominal wall gave the possibility for application of fistula and gastro stoma placement. The patient wakes up 10 minutes after the end of the procedure without using antidotes. The patient after treatment went home in two days using gastro stoma for enteral feeding.
Lokesh C Wijesekera#1 and P Nigel Leigh #1 Amyotrophic lateral sclerosis Orphanet J Rare Dis. 2009; 4: 3.Published online 2009 Feb 3. doi: 10.1186/1750-1172-4-3.
Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3–9. [PubMed] [Google Scholar]
Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328–334. [PubMed] [Google Scholar]
Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63:130–137. [PubMed] [Google Scholar]
Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, Lyall R, Moxham J, Mustfa N, Rio A, et al. The management of motor neurone disease. J Neurol Neurosurg Psychiatry. 2003;74:iv32–iv47. [PMC free article] [PubMed] [Google Scholar]
Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:921–938. [PubMed] [Google Scholar]
Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney de Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc. 1994;40:463–469. [PubMed] [Google Scholar]
Hu MT, Ellis CM, Al-Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950–951. [PMC free article][PubMed] [Google Scholar]
Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 2007;8:243–254. [PubMed] [Google Scholar]
Schrag, S.P., Sharma, R., Jaik, N.P., et al. (2007) Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A comprehensive clinical review. Journal of Gastrointestinal and Liver Diseases, 16, 407-418. [Citation Time(s):1]
Naco M, Gani H,& BP: Anesthesia in endoscopic procedutes” International Journal of Sciences& Research www.ijsr.net Online ISSN:2319-7064. Scientific Journal, research Gate Impact Factor(2018):0.28, SJIF (2018):7.426: Paper ID;ART20198205,Vol.8, Issue 5, Maj 2019..fq 1723-1735.
Strijbos D, Hofstede J, Keszthelyi D, Masclee AAM, Gilissen LPL. Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study.Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1303-1308. doi: 10.1097/MEG.0000000000000959.PMID:28877087
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.